David Altarac
David Altarac publishes mostly in Molecular Medicine, Applied Microbiology and Biotechnology and Pharmacology, on topics such as Antibiotic Resistance in Bacteria, Antibiotic Use and Resistance and Antibiotics Pharmacokinetics and Efficacy.
- World rank
- #2,986,044 of 7,710,434 ranked researchers
- Rank in United States
- #857,932 of 1,627,098
- Works
- 18
- Citations
- 979
- Citations per work
- 54.4
What does David Altarac research?
David Altarac's work is mostly in Biochemistry, Genetics and Molecular Biology (27%), Medicine (25%), Immunology and Microbiology (18%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Life Sciences845.0%
- Everything else529.6%
- Health Sciences525.4%
- Medicine525.4%
- 1Molecular Medicine20% of their works
- 2Applied Microbiology and Biotechnology18% of their works
- 3Pharmacology18% of their works
- 4Infectious Diseases8% of their works
- 5Molecular Biology4% of their works
- 6Clinical Biochemistry4% of their works
Research topics
- Antibiotic Resistance in Bacteria
- Antibiotic Use and Resistance
- Antibiotics Pharmacokinetics and Efficacy
- Bacterial Identification and Susceptibility Testing
- Bacterial biofilms and quorum sensing
- Antimicrobial Resistance in Staphylococcus
- Reproductive System and Pregnancy
- Reproductive tract infections research
Which keywords describe David Altarac's research?
The keywords of their largest research topics: Antibiotic Resistance, Epidemiology, Infectious Diseases, Antimicrobial Resistance, ESKAPE Pathogens, Multidrug-Resistant Bacteria, Antimicrobial Stewardship and Global Health.
- Vaginal Microbiome
- Regulatory T Cells
- Staphylococcus aureus
- Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry
- Biofilms
- Critically Ill Patients
- Global Health
- Multidrug-Resistant Bacteria
- Antimicrobial Resistance
- Epidemiology
- Antibiotic Resistance
- Infectious Diseases
- ESKAPE Pathogens
- Antimicrobial Stewardship
- Antibiotic Pharmacokinetics
- Bacteria
- MRSA
- Microorganism Identification
- Decidual NK Cells
- Sexually Transmitted Infections
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Antibiotic Resistance213 topics
- Epidemiology112 topics
- Infectious Diseases112 topics
- Antimicrobial Resistance102 topics
- ESKAPE Pathogens101 topic
- Multidrug-Resistant Bacteria101 topic
- Antimicrobial Stewardship91 topic
- Global Health91 topic
- Antibiotic Pharmacokinetics81 topic
- Critically Ill Patients81 topic
- Bacteria21 topic
- Biofilms21 topic
- MRSA21 topic
- Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry21 topic
- Microorganism Identification21 topic
- Staphylococcus aureus21 topic
- Decidual NK Cells11 topic
- Regulatory T Cells11 topic
- Sexually Transmitted Infections11 topic
- Vaginal Microbiome11 topic
Where does David Altarac work?
David Altarac's main affiliation in the publication record is Entasis Therapeutics (United States), United States.
How many publications and citations does David Altarac have?
OpenAlex counts 18 works and 979 citations for David Altarac, an h-index of 8, ranking #2,986,044 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about David Altarac. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.